This article examines the ethical challenges posed by the rapid advancement of CRISPR technology in genetic editing. While CRISPR offers unprecedented potential for treating genetic disorders and improving human health, it also raises profound bioethical questions regarding safety, consent, equity, and the potential for misuse. The study analyzes current international ethical frameworks and scientific guidelines to propose boundaries for responsible application. The goal is to balance innovation with respect for human dignity and social justice.

Genetic editing, CRISPR, bioethics, ethical boundaries, gene therapy, human dignity, consent, genetic modification

UNESCO. (2005). Universal Declaration on Bioethics and Human Rights.

World Health Organization. (2021). Human Genome Editing: Recommendations and Ethical Considerations.

National Academies of Sciences, Engineering, and Medicine. (2017). Human Genome Editing: Science, Ethics, and Governance.

Doudna, J.A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.

National Institutes of Health. (2023). Guidelines for Research Involving Gene Editing.

Baylis, F., & Robert, J.S. (2020). Ethics of germline gene editing. Annual Review of Genomics and Human Genetics, 21, 169–190.